CROI 2015 Program and Abstracts

General Information

CONFERENCE SCHEDULE OVERVIEW

General Information

Monday, February 23, 2015

Tuesday, February 24, 2015

Wednesday, February 25, 2015

Thursday, February 26, 2015

8:30 AM

Plenary: PrEP for HIV Prevention:WhatWe Know andWhatWe Need to Know for Implementation 4AB Auditorium Plenary: Specific HIV Integration Sites Linked to Clonal Expansion and Persistence of Cells 4AB Auditorium ORAL ABSTRACT CONCURRENT SESSIONS 10:00 AM to 12:15 PM O-1: Preventing HIV and HSV-2:WhatWill ItTake? Room 6AB O-2: Prevention, Diagnosis, andTreatment of Pediatric HIV Infection Room 613 O-3: Cellular Dynamics, Sensing, andViral Restriction Room 615 O-4: New Discoveries in HIV Pathogenesis Room 6D THEMED DISCUSSION CONCURRENT SESSIONS 1:30 PM to 2:30 PM TD-B: Next Generation of Next-Generation Sequencing Room 615 TD-C: HIV/CMV Interactions inTransmission and Pathogenesis Room 613 TD-F: Leaky Latency Room 6D TD-Q: FatWithout Borders: Metabolic Complications in Resource-Limited Settings Room 6AB TD-S: Hormonal Contraceptives: Enduring Controversy Room 6C TD-Y: Circumcision: Evolving Knowledge and Practice Room 6E LUNCH 12:15 PM to 1:30 PM

Plenary: Preventing Pediatric HIV and Managing HIV-Infected Children:Where AreWe Now and Where AreWe Going? 4AB Auditorium Plenary: Directing ChronicVirus Infection ThroughViral Regulation of Innate Immune Defenses 4AB Auditorium ORAL ABSTRACT CONCURRENT SESSIONS 10:00 AM to 12:15 PM O-6: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence Room 615 O-7: KS and Cervical/Anal Dysplasia:Tale of 2 Tumors andTB and Other OIs Room 613 O-8: Factors Affecting HIV Care and Outcome: Global Perspective Room 6E O-9: New Insights Into HIV Persistence, Latency Reversal, andViremia Rebound Room 6D

Plenary: Cardiovascular Disease in HIV Patients: An Emerging Paradigm and Call to Action 4AB Auditorium

9:00 AM Workshop for New Investigators and Trainees 9:00 AM to 12:30 PM Room 6E

Plenary: The Price of Selling Sex: HIV Among Female SexWorkers—The Context and the Public

Health Response 4AB Auditorium

9:30 AM 10:00 AM

ORAL ABSTRACT CONCURRENT SESSIONS 10:00 AM to 12:15 PM O-11: Cardiovascular, Bone, and Kidney Health Room 6C O-12: Curing HCV: Mission Accomplished Room 6AB O-13: Reaching Populations: Demonstrating Impact Room 6D O-14: Immune Mechanisms:The Road to

Protection Room 613

12:15 PM

LUNCH 12:15 PM to 1:30 PM

LUNCH 12:15 PM to 1:30 PM

12:30 PM LUNCH

12:30 PM to 1:00 PM 1:00 PM Martin Delaney Presentation 1:00 PM to 2:00 PM

1:30 PM

THEMED DISCUSSION CONCURRENT SESSIONS 1:30 PM to 2:30 PM TD-A: Interferon:Triggers and Effectors Room 615

THEMED DISCUSSION CONCURRENT SESSIONS 1:30 PM to 2:30 PM TD-M: Identifying Recent Infections: Issues of False Recency Room 615 TD-N: Next-Generation HCVTherapeutics: From ClinicalTrials to the Clinic Room 6AB TD-P: Cardiovascular Risk Prediction: CanWe Do Better? Room 6E TD-T: Keys to the Kingdom:Viral Suppression in Pregnant and PostpartumWomen Room 6D TD-V: PEP: Remember Me? Room 6C

How to End the HIV Epidemic: Community Perspectives Room 6E

TD-H: NewTechnologies in Assessing Drug Interactions and Systemic and Intracellular Pharmacology Room 613 TD-O: Cancers inYoung and Old, and Lung Cancer in HIV Room 6D TD-R: Cryptococcal Meningitis: Host Response, Treatment, and Outcomes Room 6E TD-W: Serosorting and Seroadaptive Behavior: What’sYour Position? Room 6AB TD-Z: Economic Implications of ART Room 6C

2:00 PM

vii

CROI 2015